Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
INIS
patients
100%
risks
62%
diseases
48%
sleep
46%
colombia
45%
levels
40%
adults
39%
populations
33%
control
30%
reviews
27%
cardiovascular diseases
26%
cholesterol
24%
lipids
23%
management
23%
therapy
18%
plasma
18%
recommendations
18%
inflammation
17%
humans
17%
hybrids
17%
values
16%
hospitals
16%
palm oil
16%
malnutrition
16%
women
15%
interventions
15%
lipoproteins
14%
drugs
13%
comparative evaluations
13%
genetics
13%
coronaries
13%
cities
12%
guidelines
11%
altitude
11%
insulin
11%
arthritis
11%
lungs
11%
olive oil
11%
density
10%
triglycerides
10%
reduction
10%
men
10%
screening
10%
capacity
9%
children
9%
genes
9%
mortality
8%
data
8%
biological markers
8%
universities
8%
latin america
8%
phenotype
8%
myocardial infarction
7%
surveys
7%
fatty acids
7%
symptoms
7%
glucose
7%
cytokines
7%
tools
7%
detection
6%
morbidity
6%
emergencies
6%
panels
6%
blood
6%
workers
5%
risk assessment
5%
simulation
5%
tissues
5%
errors
5%
antioxidants
5%
erythrocytes
5%
phospholipids
5%
membranes
5%
skin
5%
epidemiology
5%
prostaglandins
5%
delivery
5%
staphylococcus
5%
covid-19
5%
asthma
5%
philippines
5%
fees
5%
japan
5%
pediatrics
5%
germany
5%
insurance
5%
thickness
5%
dialysis
5%
c-reactive protein
5%
ucla
5%
regulations
5%
disturbances
5%
performance
5%
Keyphrases
Colombia
40%
Dyslipidemia
28%
Colombian
27%
Homozygous Familial Hypercholesterolemia (HoFH)
25%
Periodontal Disease
23%
Cardiovascular Disease
19%
Hybrid Palm Oil
16%
Malnutrition Screening Tool
15%
Obstructive Sleep Apnea-hypopnea Syndrome (OSAHS)
12%
Oil Supplementation
12%
Hospitalized Patients
12%
Sleep Disorders
11%
Acute Coronary Syndrome
11%
Endothelial Dysfunction
11%
Molecular Aspects
11%
Extra Virgin Olive Oil
11%
Low-density Lipoprotein Cholesterol (LDL-C)
10%
Polysomnography
10%
Ezetimibe
10%
Acute Myocardial Infarction
10%
High-density Lipoprotein Cholesterol (HDL-C)
10%
Obstructive Sleep Apnea
10%
Malnutrition
9%
Poor Sleep
9%
Risk Factors
9%
Hospital Admission
9%
University Hospital
8%
Malnutrition Prevalence
8%
Clinical Practice Guidelines
8%
Adult Population
8%
Statin Therapy
8%
Human Plasma
8%
Elaeis Oleifera
8%
Bogota, Colombia
8%
Waist Circumference
8%
Latin America (LATAM)
8%
Latin American
7%
Evolocumab
7%
Cardiovascular Risk
7%
Periodontitis
7%
Disease Burden
7%
Sleep Quality
7%
Narrative Review
7%
Pre-diabetes (pre-DM)
7%
High Complexity
6%
Web-based
6%
Colombian Cities
6%
Clinical Practice
6%
Plasma Lipids
6%
Clinical Aspects
6%
Randomized Trial
6%
Cardiovascular Events
6%
Adult Patients
6%
Flow-mediated Dilation
6%
Triglycerides
6%
Anthropometric Measurements
6%
Three-City
6%
Total Cholesterol
6%
Insomnia
6%
Neck Circumference
6%
Statins
6%
Low-density Lipoprotein Cholesterol Level
6%
Body Mass Index
5%
Healthcare Workers
5%
Soft Tissue Infection
5%
Skin Tissue
5%
Familiar Hypercholesterolemia
5%
Consumo
5%
Path Management
5%
Inpatient Population
5%
RAND/UCLA Appropriateness Method
5%
COVID-19
5%
Hypoglycemia Risk
5%
Metabolic Risk Factors
5%
Metabolic Control
5%
Ultrasensitive
5%
Variablity
5%
Statin Drugs
5%
Promising Therapy
5%
Care Pathway
5%
Depressive Substance
5%
Mayors
5%
Regulatory Components
5%
Myocardial Infarction
5%
Systematic Literature Review
5%
Perceived Stress
5%
Human Erythrocyte Membrane
5%
Lipid Pattern
5%
Cardiovascular Risk Assessment
5%
Pharmacological Management
5%
Detection/diagnosis
5%
Sleep Traits
5%
Smoking Patients
5%
Systemic Inflammation Biomarkers
5%
Diabetes Disease
5%
Early Detection
5%
Quality of Glycemic Control
5%
Hyperactive Disorder
5%
Genetic Test
5%
Peritoneal Dialysis
5%
Medicine and Dentistry
Periodontal Disease
28%
Diseases
18%
Familial Hypercholesterolemia
17%
Dyslipidemia
17%
Obstructive Sleep Apnea
11%
Endothelial Dysfunction
11%
Sleep Disorder
11%
Malnutrition
11%
Cardiovascular Disease
10%
Lipid
9%
Periodontitis
9%
Diabetes
8%
Evolocumab
7%
Myocardial Infarction
7%
Glycemic
6%
Hypercholesterolemia
6%
Anthropometry
6%
Neck
6%
Hypoglycemia
6%
Acute Heart Infarction
5%
Cardiovascular Risk
5%
Biological Marker
5%
Intima-Media Thickness
5%
Anticoagulation
5%
Glycemic Control
5%
Care Pathway
5%
Cohort Effect
5%
Latanoprost Plus Timolol
5%
Carvedilol
5%
Silo-Filler's Disease
5%
Supplementation
5%
Patient with Asthma
5%
Triage
5%
C Reactive Protein
5%
Rheumatoid Arthritis
5%
Chylomicronemia
5%
4 Iodo 2,5 Dimethoxyamphetamine
5%
Physical Examination
5%
Arrhythmia
5%
Inflammatory Arthritis
5%
Soft Tissue Infection
5%
Acute Coronary Syndrome
5%
Preterm Delivery
5%
Methicillin Resistant Staphylococcus Aureus
5%
Polysomnography
5%
Pediatrics
5%
Patient with Heart Disease
5%
Hyperactivity
5%
Inflammation
5%
Prostaglandin E2
5%
Genetics
5%
Inflammatory Cytokine
5%
Premature Labor
5%
Attention Deficit Disorder
5%
Peritoneal Dialysis
5%
Patient with Diabetes
5%
Insulin
5%
Metabolic Regulation
5%
Prevalence
5%
Statin
5%